MN58b
MN58b is a selective choline kinase α (CHKα) inhibitor, and results in inhibition of phosphocholine synthesis. MN58b reduces cell growth through the induction of apoptosis, and also has antitumoral activity[1][2].
Product Specifications
CAS Number
203192-01-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mn58b.html
Purity
99.78
Solubility
DMSO : 14.71 mg/mL (ultrasonic)
Smiles
CN(C)C1=CC=[N+](C=C1)CC2=CC=C(CCCCC3=CC=C(C[N+]4=CC=C(N(C)C)C=C4)C=C3)C=C2.[Br-].[Br-]
Molecular Formula
C32H40Br2N4
Molecular Weight
640.49
Precautions
H302, H315, H319, H335
References & Citations
[1]Mazarico JM, et al. Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors. Mol Cancer Ther. 2016 Feb;15 (2) :323-33.|[2]Al-Saffar NM, et al. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res. 2006 Jan 1;66 (1) :427-34.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx382787 96 Tests
Human RPE-retinal G protein-coupled receptor (RGR) ELISA Kit
Sign In for Pricing
View Details 
T6307 1x106 cells / 1.0 mL
CC CKR2B Stable Expressing L1.2 Cell Line
Sign In for Pricing
View Details 
